EUVIMEDEUVIMED entdecken
Klinische Studie (Phase I)Open Access · CC BY-NC 3.0

Phase I Trial of Pegylated Liposomal Doxorubicin Combined with Ifosfamide for Advanced Soft Tissue Sarcoma

Ting Ye, Li Fan, Rubo Cao, Ling Peng, Jing Chen iD

Drug Design, Development and Therapy · 2025

DOI: 10.2147/dddt.s529231 ↗

Kurz gefasst

Klinische Studie (Phase I) in der Zeitschrift Drug Design, Development and Therapy, 2025. Verfasst von Ting Ye und 4 weiteren Autor:innen. Beteiligte Einrichtung: Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, People's Republic of China. Hauptthemen laut MEDLINE: Antineoplastic Combined Chemotherapy Protocols, Doxorubicin, Ifosfamide, Sarcoma. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antineoplastic Combined Chemotherapy ProtocolsDoxorubicinIfosfamideSarcomaAdultAgedFemaleHumansMaleMiddle AgedDose-Response Relationship, DrugMaximum Tolerated DosePolyethylene Glycols

Stichwörter der Autor:innen

dose-escalationifosfamidepegylated liposomal doxorubicinsafetysoft tissue sarcomas

Substanzen

DoxorubicinIfosfamideliposomal doxorubicinPolyethylene Glycols

Autor:innen und Institutionen

  • Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, People's Republic of China.
  • Hubei Key Laboratory of Precision Radiation Oncology, Wuhan, 430022, People's Republic of China.
  • Institute of Radiation Oncology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, People's Republic of China.

ORCID-Profile: Jing Chen

Zitieren

APA

Ye, T., Fan, L., Cao, R., Peng, L., & Chen, J. (2025). Phase I Trial of Pegylated Liposomal Doxorubicin Combined with Ifosfamide for Advanced Soft Tissue Sarcoma. Drug Design, Development and Therapy. https://doi.org/10.2147/dddt.s529231

Vancouver

Ye T, Fan L, Cao R, Peng L, Chen J. Phase I Trial of Pegylated Liposomal Doxorubicin Combined with Ifosfamide for Advanced Soft Tissue Sarcoma. Drug Design, Development and Therapy. 2025. doi:10.2147/dddt.s529231

BibTeX
@article{Ye2025,
  author = {Ye, Ting and Fan, Li and Cao, Rubo and Peng, Ling and Chen, Jing},
  title = {Phase I Trial of Pegylated Liposomal Doxorubicin Combined with Ifosfamide for Advanced Soft Tissue Sarcoma},
  journal = {Drug Design, Development and Therapy},
  year = {2025},
  doi = {10.2147/dddt.s529231}
}
Kostenlos starten →